Kevin T Conroy Adaptive Biotechnologies Corp (ADPT) insider trading activity

ADPT Quotes by TradingView

Kevin T Conroy is Director of Adaptive Biotechnologies Corp. Currently has a direct ownership of 22,968 shares of ADPT, which is worth approximately $81,306. The most recent transaction as insider was on Mar 06, 2023, when has been sold 14,775 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23K
0% 3M change
0% 12M change
Total Value Held $81,306

Kevin T Conroy Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 06 2023
BUY
Grant, award, or other acquisition
-
14,775 Added 39.15%
22,968 Common Stock
Jan 26 2022
BUY
Grant, award, or other acquisition
-
6,689 Added 44.95%
8,193 Common Stock
Feb 14 2021
BUY
Grant, award, or other acquisition
-
1,504 Added 50.0%
1,504 Common Stock

Also insider at

EPZM
Epizyme, Inc. Healthcare
Director
EXAS
EXACT SCIENCES CORP Healthcare
President and CEO
SLGC
SomaLogic, Inc. Healthcare
Director
ALGN
ALIGN TECHNOLOGY INC Healthcare
KTC

Kevin T Conroy

Director
Madison, WI

Track Institutional and Insider Activities on ADPT

Follow Adaptive Biotechnologies Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADPT shares.

Notify only if

Insider Trading

Get notified when an Adaptive Biotechnologies Corp insider buys or sells ADPT shares.

Notify only if

News

Receive news related to Adaptive Biotechnologies Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ADPT